ifosfamide has been researched along with Anaplastic Astrocytoma in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our objective was to assess the efficacy, security, and survival rate of postoperative chemotherapy with ifosfamide, carboplatin, and etoposide (ICE) in pediatric patients with anaplastic astrocytomas (AA) and glioblastoma multiforme (GM)." | 9.10 | Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children. ( Cerecedo-Díaz, F; Delgado-Huerta, S; Hernández-Contreras, I; López-Aguilar, E; Ramón-García, G; Rivera-Márquez, H; Rodríguez-Jiménez, H; Romo-Rubio, HA; Santacruz-Castillo, E; Sepúlveda-Vildósola, AC; Valdés-Sánchez, M; Wanzke-del Angel, V, 2003) |
| "Sixteen patients who developed CT or MRI scan evidence of recurrent diffuse astrocytoma after radiation therapy and nitrosourea-containing chemotherapy received ifosfamide (2500 mg/m2/day for 3 consecutive days) and mesna (500 mg/m2/dose, 5 doses/day for 3 consecutive days)." | 7.68 | Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma. ( Buckner, JC; Cascino, TL; Elliott, TE; Levitt, R; O'Fallon, JR; Scheithauer, BW, 1991) |
| " Our objective was to assess the efficacy, security, and survival rate of postoperative chemotherapy with ifosfamide, carboplatin, and etoposide (ICE) in pediatric patients with anaplastic astrocytomas (AA) and glioblastoma multiforme (GM)." | 5.10 | Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children. ( Cerecedo-Díaz, F; Delgado-Huerta, S; Hernández-Contreras, I; López-Aguilar, E; Ramón-García, G; Rivera-Márquez, H; Rodríguez-Jiménez, H; Romo-Rubio, HA; Santacruz-Castillo, E; Sepúlveda-Vildósola, AC; Valdés-Sánchez, M; Wanzke-del Angel, V, 2003) |
| "Sixteen patients who developed CT or MRI scan evidence of recurrent diffuse astrocytoma after radiation therapy and nitrosourea-containing chemotherapy received ifosfamide (2500 mg/m2/day for 3 consecutive days) and mesna (500 mg/m2/dose, 5 doses/day for 3 consecutive days)." | 3.68 | Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma. ( Buckner, JC; Cascino, TL; Elliott, TE; Levitt, R; O'Fallon, JR; Scheithauer, BW, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schäfer, N | 1 |
| Tichy, J | 1 |
| Thanendrarajan, S | 1 |
| Kim, Y | 1 |
| Stuplich, M | 1 |
| Mack, F | 1 |
| Rieger, J | 1 |
| Simon, M | 1 |
| Scheffler, B | 1 |
| Boström, J | 1 |
| Steinbach, JP | 1 |
| Herrlinger, U | 1 |
| Glas, M | 1 |
| López-Aguilar, E | 1 |
| Sepúlveda-Vildósola, AC | 1 |
| Rivera-Márquez, H | 1 |
| Cerecedo-Díaz, F | 1 |
| Valdés-Sánchez, M | 1 |
| Delgado-Huerta, S | 1 |
| Wanzke-del Angel, V | 1 |
| Ramón-García, G | 1 |
| Rodríguez-Jiménez, H | 1 |
| Hernández-Contreras, I | 1 |
| Santacruz-Castillo, E | 1 |
| Romo-Rubio, HA | 1 |
| Heideman, RL | 1 |
| Douglass, EC | 1 |
| Langston, JA | 1 |
| Krischer, JP | 1 |
| Burger, PC | 1 |
| Kovnar, EH | 1 |
| Kun, LE | 1 |
| Friedman, HS | 1 |
| Kadota, R | 1 |
| Elliott, TE | 1 |
| Buckner, JC | 1 |
| Cascino, TL | 1 |
| Levitt, R | 1 |
| O'Fallon, JR | 1 |
| Scheithauer, BW | 1 |
2 trials available for ifosfamide and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Central Nervou | 2003 |
A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Carcinoma; Child | 1995 |
2 other studies available for ifosfamide and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplat | 2011 |
Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.
Topics: Adolescent; Adult; Aged; Astrocytoma; Blood Cell Count; Brain Neoplasms; Drug Evaluation; Humans; If | 1991 |